Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy

Clinical Nephrology

Volumn 78, Issue 6, 2012, Pages 456-464

  Li, Ping ^a   Wei, Ri Bao ^a   Tang, Li ^a   Wu, Jie ^a   Zhang, Xue Guang ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Clinical manifestation; Hepatitis B virus; Membranous glomerulo; nephritis; Pathology

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; HEMOGLOBIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NITROGEN; PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMPLEMENT BLOOD LEVEL; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS RELATED MEMBRANOUS NEPHROPATHY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; NEPHROTIC SYNDROME; ONSET AGE; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; SEX RATIO; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B; HUMANS; KIDNEY; MALE; MIDDLE AGED;

EID: 84871540901     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107615     Document Type: Article

References (43)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373: 582-592.
2. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003; 362: 2089-2094.
3. Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis. 2004; 8: 403-418.
4. Pyrsopoulos NT, Reddy KR. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep. 2001; 3: 71-78.
5. Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, Carter NW. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971; 2: 234-237.
6. Wei RB, Li P, Wu J, Zhang XG, Yin Z, Shi SZ, Chen XM. [Clinicopathological analysis on hepatitis B virus-associated glomerulonephritis in 205 patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010; 24: 464-467.
7. White RP, Hagen A, Robertson JT. Experimental evaluation of the spasmogenicity of dopamine on the basilar artery. J Neurosurg. 1976; 44: 45-49.
8. Katafuchi R, Oh Y, Hori K, Komota T, Yanase T, Ikeda K, Omura T, Fujimi S. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol. 1994; 41: 191-198.
9. Cacoub P, Saadoun D, Bourlière M, Khiri H, Martineau A, Benhamou Y, Varastet M, Pol S, Thibault V, Rotily M, Halfon P. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol. 2005; 43: 764-770.
10. Lin CY. Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int Suppl. 1991; 35: S46-S53.
11. Coovadia HM, Adhikari M, Moodley D. Hepatitis B 's' and 'e' antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis. Ann Trop Paediatr. 1993; 13: 79-82.
12. Panomsak S, Lewsuwan S, Eiam-Ong S, Kanjanabuch T. Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. J Med Assoc Thai. 2006; 89 (Suppl 2): S151-S156.
13. Wen YK, Chen ML. Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy. Clin Nephrol. 2006; 65: 211-215.
14. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol. 1994; 8: 11-14.
15. Takekoshi Y, Tochimaru H, Nagata Y, Itami N. Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int Suppl. 1991; 35: S34-S39.
16. Lai KN, Lai FM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl. 1991; 35: S40-S45.
17. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990; 37: 663-676.
18. Churg J, Ehrenreich T. Membranous nephropathy. Perspect Nephrol Hypertens. 1973; 1: 443-448.
19. Ehrenreich T, Porush JG, Churg J, Garfinkel L, Glabman S, Goldstein MH, Grishman E, Yunis SL. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976; 295: 741-746.
20. Teloh HA. Serum proteins in hepatic disease. Ann Clin Lab Sci. 1978; 8: 127-129.
21. Mastoi AA, Devrajani BR, Shah SZ, Rohopoto Q, Memon SA, Baloch M, Qureshi GA, Sami W. Metabolic investigations in patients with hepatitis B and C. World J Gastroenterol. 2010; 16: 603-607.
22. Lee WC, Lin HC, Hou MC, Lin HY, Lee FY, Wang SS, Chang FY, Lee SD. Serum uric acid levels in patients with cirrhosis: a reevaluation. J Clin Gastroenterol. 1999; 29: 261-265.
23. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc. 2004; 103: 286-291.
24. Beckebaum S, Sotiropoulos GC, Klein CG, Broelsch CE, Saner F, Paul A, Gerken G, Cicinnati VR. Predictive factors of outcome in patients transplanted for hepatitis B. Transplantation. 2009; 87: 872-881.
25. Potter BJ, Elias E, Fayers PM, Jones EA. Profiles of serum complement in patients with hepatobiliary diseases. Digestion. 1978; 18: 371-383.
26. Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int. 1980; 17: 1-13.
27. Ito H, Hattori S, Matusda I, Amamiya S, Hajikano H, Yoshizawa H, Miyakawa Y, Mayumi M. Hepatitis Be antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli. Lab Invest. 1981; 44: 214-220.
28. Hirose H, Udo K, Kojima M, Takahashi Y, Miyakawa Y, Miyamoto K, Yoshizawa H, Mayumi M. Deposition of hepatitis Be antigen in membranous glomerulonephritis: identification by F(ab')2 fragments of monoclonal antibody. Kidney Int. 1984; 26: 338-341.
29. Mason A, Theal J, Bain V, Adams E, Perrillo R. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol. 2005; 100: 972-976.
30. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004; 24: 198-211.
31. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med. 1987; 63: 323-333.
32. Lai KN, Lai FM, Tam JS, Chow CB, Au TC. High prevalence of hepatitis B surface antigenaemia in nephrotic syndrome in Hong Kong. Ann Trop Paediatr. 1989; 9: 45-48.
33. Levy M, Kleinknecht C. Membranous glomerulonephritis and hepatitis B virus infection. Nephron. 1980; 26: 259-265.
34. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med. 1991; 324: 1457-1463.
35. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 1990; 54: 12-17.
36. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC. Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol. 2002; 17: 393-399.
37. Xu G, Huang T. Hepatitis B virus-associated glomerular nephritis in East Asia: progress and challenges. Eur J Intern Med. 2011; 22: 161-166.
38. Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Metaanalysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol. 2012; 18: 821-832.
39. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 1995; 47: 225-230.
40. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology. 1995; 109: 540-546.
41. Chung DR, Yang WS, Kim SB, Yu E, Chung YH, Lee Y, Park JS. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol. 1997; 17: 112-117.
42. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int. 2005; 68: 1750-1758.
43. Fabrizi F, Dixit V, Martin P. Meta-analysis: antiviral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther. 2006; 24: 781-788.